AbbVie Inc (ABBV)
Return on equity (ROE)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 4,278,000 | 5,122,000 | 5,339,000 | 5,993,000 | 4,863,000 | 6,514,000 | 8,685,000 | 7,585,000 | 11,836,000 | 13,407,000 | 12,637,000 | 12,479,000 | 11,542,000 | 7,534,000 | 6,663,000 | 5,159,000 | 4,616,000 | 7,381,000 | 6,957,000 | 8,436,000 |
| Total stockholders’ equity | US$ in thousands | 3,325,000 | 6,032,000 | 6,778,000 | 8,007,000 | 10,360,000 | 12,094,000 | 12,866,000 | 13,274,000 | 17,254,000 | 15,994,000 | 14,653,000 | 16,283,000 | 15,408,000 | 13,550,000 | 12,569,000 | 13,710,000 | 13,076,000 | 15,270,000 | 14,708,000 | -7,415,000 |
| ROE | 128.66% | 84.91% | 78.77% | 74.85% | 46.94% | 53.86% | 67.50% | 57.14% | 68.60% | 83.83% | 86.24% | 76.64% | 74.91% | 55.60% | 53.01% | 37.63% | 35.30% | 48.34% | 47.30% | — |
December 31, 2024 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $4,278,000K ÷ $3,325,000K
= 128.66%
AbbVie Inc's Return on Equity (ROE) has shown a fluctuating trend over the years based on the provided data. The ROE increased steadily from June 2020 to June 2022, indicating improved efficiency in generating profits from shareholders' equity.
The ROE reached its peak at the end of December 2024 with a value of 128.66%, reflecting the company's ability to generate a substantial return on shareholders' investments.
However, the ROE experienced a slight decline in the first quarter of 2023 before picking up again. This fluctuation could be attributed to changes in the company's financial performance and capital structure during this period.
Overall, AbbVie Inc's ROE performance over the years demonstrates a mix of strong returns and variations, indicating the company's effectiveness in utilizing shareholder equity to generate profits.
Peer comparison
Dec 31, 2024